This episode, titled Optimizing Subcutaneous Therapies in NSCLC: Practical Integration, Patient Selection, and Workflow ...
KORU Medical Systems receives EU MDR Certification for the Freedom60 Infusion Pump with prefilled syringe compatibility: Mahwah, New Jersey Monday, March 16, 2026, 12:00 Hrs [IST] ...
The Freedom60 Infusion Pump is designed to support dosing with 50 ml prefilled syringes, while the FreedomEDGE® Infusion System provides a compatible option for 20 mL prefilled syringe formats.
Medical Device Network on MSN
KORU Medical secures certification under EU MDR for infusion pump
The certification expands access to Freedom60 and FreedomEDGE infusion pumps for growing SCIg prefilled syringe use.
KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and ...
KORU Medical Systems, Inc. KRMD recently announced that its Freedom60 Infusion Pump — along with an adapter designed for 50 mL prefilled syringes — has secured certification under the European Union ...
The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use adopted a positive opinion for Onerji (levodopa/carbidopa, Tanabe Pharma) for the treatment of adults with ...
KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and ...
Precision Bb Targeting, Robust Efficacy, Transfusion Independence, Excellent Safety in Phase II PNH Study, and Subcutaneous Administration The 12-16-week open-label study evaluated Ruxoprubart as ...
Rani Therapeutics will host a conference call and live webcast at 4:30 p.m. ET / 1:30 p.m. PT on March 26, 2026. Individuals interested in listening to the live conference call may do so by using the ...
Subcutaneous immunotherapy for cancer can cause many of the same side effects as intravenous (IV) immunotherapy because it involves the same medications. Injection site reactions are a common but ...
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results